Valker A. Feitosa - Publications

Oral drug delivery systems for companion animals: an integrative review of medicated treats, chewable tablets, and other pharmaceutical formulations.

Journal: Brazilian journal of veterinary medicine

Published: March 14, 2026

Epidemiological profile, completeness of notifications, and factors associated with the adequacy of treatment for syphilis during pregnancy: a cross-sectional study, Ubá, 2018-2023.

Journal: Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil

Published: September 19, 2025

Development of a dry powder formulation for pulmonary delivery of azithromycin-loaded nanoparticles.

Journal: Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques

Published: August 07, 2024

Exploring the Thermal-Oxidative Stability of Azithromycin Using a Thermoactivated Sensor Based on Cerium Molybdate and Multi-Walled Carbon Nanotubes.

Journal: Nanomaterials (Basel, Switzerland)

Published: April 10, 2024

Endochitinase and Chitobiosidase Production by Marine Aeromonas caviae CHZ306: Establishment of Nitrogen Supplementation.

Journal: Bioengineering (Basel, Switzerland)

Published: January 12, 2023

Effects of Oxygen Transference on Protease Production by Rhodotorula mucilaginosa CBMAI 1528 in a Stirred Tank Bioreactor.

Journal: Bioengineering (Basel, Switzerland)

Published: August 18, 2022

Enhanced production of N-acetyl-glucosaminidase by marine Aeromonas caviae CHZ306 in bioreactor.

Journal: Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]

Published: May 31, 2022

Renal amyloidosis: a new time for a complete diagnosis.

Journal: Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica

Published: April 13, 2022

Lysine-PEGylated Cytochrome C with Enhanced Shelf-Life Stability.

Journal: Biosensors

Published: December 31, 2021

Potentiation of combined p19Arf and interferon-beta cancer gene therapy through its association with doxorubicin chemotherapy.

Journal: Scientific reports

Published: December 02, 2021

Doxorubicin nanoformulations on therapy against cancer: An overview from the last 10 years.

Journal: Biomaterials advances

Published: August 14, 2021

Building better biobetters: From fundamentals to industrial application.

Journal: Drug discovery today

Published: March 02, 2021